134 related articles for article (PubMed ID: 25466630)
1. High efficiency targeting of IFN-α activity: possible applications in fighting tumours and infections.
Uzé G; Tavernier J
Cytokine Growth Factor Rev; 2015 Apr; 26(2):179-82. PubMed ID: 25466630
[TBL] [Abstract][Full Text] [Related]
2. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S
Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566
[TBL] [Abstract][Full Text] [Related]
3. Understanding Interferon Subtype Therapy for Viral Infections: Harnessing the Power of the Innate Immune System.
Berry CM
Cytokine Growth Factor Rev; 2016 Oct; 31():83-90. PubMed ID: 27544015
[TBL] [Abstract][Full Text] [Related]
4. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
Walter MR; Bordens R; Nagabhushan TL; Williams BR; Herberman RB; Dinarello CA; Borden EC; Trotta PP; Pestka S; Pfeffer LM
Cancer Biother Radiopharm; 1998 Jun; 13(3):143-54. PubMed ID: 10850350
[TBL] [Abstract][Full Text] [Related]
5. [Interferon].
Vargas Vorackova F; Mata Mendoza JM
Rev Invest Clin; 1981; 33(4):419-25. PubMed ID: 6173909
[No Abstract] [Full Text] [Related]
6. [Dose-dependent effects of neuroimmunomodulator interferon alpha on behavior of humans and animals].
Loseva EV; Loginova NA; Akmaev IG
Ross Fiziol Zh Im I M Sechenova; 2009 Dec; 95(12):1397-406. PubMed ID: 20141049
[TBL] [Abstract][Full Text] [Related]
7. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
8. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
9. Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes.
Wittling MC; Cahalan SR; Levenson EA; Rabin RL
Front Immunol; 2020; 11():605673. PubMed ID: 33542718
[TBL] [Abstract][Full Text] [Related]
10. IFN-lambda therapy: current status and future perspectives.
Lasfar A; Zloza A; Cohen-Solal KA
Drug Discov Today; 2016 Jan; 21(1):167-171. PubMed ID: 26552337
[TBL] [Abstract][Full Text] [Related]
11. Interferon-Gamma: Treatment Horizons.
Khryanin AA; Reshetinikov OV
Antibiot Khimioter; 2016 Aug; 61():35-40. PubMed ID: 29874451
[TBL] [Abstract][Full Text] [Related]
12. A dance between interferon-alpha/beta and p53 demonstrates collaborations in tumor suppression and antiviral activities.
Pestka S
Cancer Cell; 2003 Aug; 4(2):85-7. PubMed ID: 12957282
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha as an immunotherapeutic protein.
Brassard DL; Grace MJ; Bordens RW
J Leukoc Biol; 2002 Apr; 71(4):565-81. PubMed ID: 11927642
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a single amino acid substitution at position 79 of human IFN-α2b in interferon-receptor assembly and activity.
Talebi S; Saeedinia A; Zeinoddini M; Ahmadpour F; Sadeghizadeh M
Prep Biochem Biotechnol; 2019; 49(8):735-743. PubMed ID: 31135267
[TBL] [Abstract][Full Text] [Related]
15. Type I Interferon in Chronic Virus Infection and Cancer.
Snell LM; McGaha TL; Brooks DG
Trends Immunol; 2017 Aug; 38(8):542-557. PubMed ID: 28579323
[TBL] [Abstract][Full Text] [Related]
16. Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation.
Frey K; Zivanovic A; Schwager K; Neri D
Integr Biol (Camb); 2011 Apr; 3(4):468-78. PubMed ID: 21225052
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and functional characterization of eleven subtypes of interferon-α in Amur tigers (Panthera tigris altaica).
Zhao H; Ma J; Wang Y; Liu J; Shao Y; Li J; Jiang G; Xing M
Dev Comp Immunol; 2017 Dec; 77():46-55. PubMed ID: 28751224
[TBL] [Abstract][Full Text] [Related]
18. [Anti-viral proteins: from interferon alpha to its receptor].
Chieux V; Hober D; Chehadeh W; Wattr P
Ann Biol Clin (Paris); 1999 May; 57(3):283-90. PubMed ID: 10377478
[TBL] [Abstract][Full Text] [Related]
19. [Interferon--a new therapeutic principle].
Micksche M
Wien Med Wochenschr; 1993; 143(16-17):408-12. PubMed ID: 8273362
[TBL] [Abstract][Full Text] [Related]
20. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
